DTC
IMVT icon

Deep Track Capital’s Immunovant IMVT Stock Holding History

Deep Track Capital’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360M Sell
9,341,151
-2,185,820
-19% -$66.6M 5.24% 2
2026
Q1 		$286M Hold
11,526,971
– – 4.68% 3
2025
Q4 		$293M Buy
11,526,971
+1,798,126
+18% +$40.1M 5.22% 2
2025
Q3 		$157M Buy
9,728,845
+228,845
+2% +$3.7M 4.38% 7
2025
Q2 		$152M Hold
9,500,000
– – 4.87% 7
2025
Q1 		$162M Buy
9,500,000
+3,500,000
+58% +$73.2M 5.26% 4
2024
Q4 		$149M Buy
6,000,000
+1,652,536
+38% +$46.9M 5.54% 4
2024
Q3 		$124M Buy
4,347,464
+1,463,728
+51% +$43.2M 3.93% 5
2024
Q2 		$76.1M Buy
2,883,736
+2,390,384
+485% +$68M 2.27% 18
2024
Q1 		$15.9M Sell
493,352
-506,648
-51% -$18.5M 0.46% 47
2023
Q4 		$42.1M Sell
1,000,000
-1,797,955
-64% -$66.2M 1.41% 30
2023
Q3 		$107M Sell
2,797,955
-2,623,375
-48% -$59.3M 4.15% 6
2023
Q2 		$103M Sell
5,421,330
-2,011,387
-27% -$37.5M 4.76% 6
2023
Q1 		$115M Sell
7,432,717
-2,277,283
-23% -$39.5M 4.73% 4
2022
Q4 		$172M Sell
9,710,000
-150,246
-2% -$1.89M 7.24% 1
2022
Q3 		$55M Buy
9,860,246
+405,246
+4% +$1.98M 2.52% 12
2022
Q2 		$36.9M Buy
9,455,000
+2,230,387
+31% +$9.63M 2.42% 18
2022
Q1 		$39.8M Buy
7,224,613
+2,449,613
+51% +$15.3M 2.55% 14
2021
Q4 		$40.7M Buy
+4,775,000
New +$39.4M 2.87% 13

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Deep Track Capital's IMVT Position: Q2 2026 in Review

Deep Track Capital reduced its Immunovant (IMVT) stake by 19% in Q2 2026, selling an estimated $66.6M and leaving 9,341,151 shares worth $360M. The position accounts for 5.24% of the portfolio, ranked #2.

Deep Track Capital first reported a position in IMVT in Q4 2021 and has held it in 19 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Deep Track Capital held 9,341,151 shares of Immunovant worth $360M as of Q2 2026.
  • Deep Track Capital sold 2,185,820 Immunovant shares in Q2 2026, an estimated $66.6M.
  • Immunovant made up 5.24% of Deep Track Capital's portfolio in Q2 2026, its #2 holding.
  • Deep Track Capital first reported a position in Immunovant in Q4 2021 and has held it in 19 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.